Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dover all silicone catheter female 12Ch-18Ch
21020000622
|
Dover all silicone catheter female 12Ch-18Ch | Catheters | Appliances | No data available |
|
Dover all silicone catheter female 12Ch-18Ch 10ml
21020000621
|
Dover all silicone catheter female 12Ch-18Ch 10ml | Catheters | Appliances | No data available |
|
Dover Silver catheter male 12Ch-24Ch
21020000725
|
Dover Silver catheter male 12Ch-24Ch | Catheters | Appliances | No data available |
|
Dovonex 50micrograms/ml scalp solution
1305020D0BBACAC
|
Dovonex | Calcipotriol | Skin | No data available |
|
Doxapram 100mg/5ml solution for injection ampoules
0305010W0AAAAAA
|
Doxapram hydrochloride | Doxapram hydrochloride | Respiratory System | No data available |
|
Doxazosin 16mg/5ml oral suspension
0205040D0AAAWAW
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 2.5mg/5ml oral liquid
0205040D0AAATAT
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 2mg/5ml oral liquid
0205040D0AAAIAI
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 3mg/5ml oral liquid
0205040D0AAAPAP
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 4mg capsules
0205040D0AAAFAF
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 500micrograms/5ml oral liquid
0205040D0AAAUAU
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 5mg/5ml oral liquid
0205040D0AAAKAK
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 6mg/5ml oral liquid
0205040D0AAASAS
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 80mg/5ml oral liquid
0205040D0AAAVAV
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxazosin 8mg/5ml oral liquid
0205040D0AAAHAH
|
Doxazosin mesilate (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Doxepin 75mg capsules
0403010L0AAADAD
|
Doxepin | Doxepin | Central Nervous System | No data available |
|
Doxorubicin (liposomal) 50mg inf vials
0801020K0AAAHAH
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg powder for solution for injection vials
0801020K0AAAAAA
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/2ml solution for injection vials
0801020K0AAAIAI
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/5ml solution for injection Cytosafe vials
0801020K0BCAEAC
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 10mg/5ml solution for injection vials
0801020K0AAACAC
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 200mg/100ml inj Cytosafe vials
0801020K0BCAGAJ
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 200mg/100ml solution for infusion vials
0801020K0AAAJAJ
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg powder for solution for injection vials
0801020K0AAABAB
|
Doxorubicin hydrochloride | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Doxorubicin 50mg/25ml solution for injection Cytosafe vials
0801020K0BCAFAD
|
Doxorubicin (Cytosafe) | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.